<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">24242756</PMID>
      <DateCompleted>
        <Year>2014</Year>
        <Month>09</Month>
        <Day>02</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>10</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1573-7373</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>116</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2014</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of neuro-oncology</Title>
          <ISOAbbreviation>J Neurooncol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Glioblastoma treatment using perphenazine to block the subventricular zone's tumor trophic functions.</ArticleTitle>
        <Pagination>
          <StartPage>207</StartPage>
          <EndPage>212</EndPage>
          <MedlinePgn>207-12</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s11060-013-1308-y</ELocationID>
        <Abstract>
          <AbstractText>We present here a potential new treatment adjunct for glioblastoma. Building on murine studies, a series of papers appeared recently showing that therapeutic irradiation of the ipsilateral subventricular zone (SVZ) retards growth of more peripherally growing cortical glioblastomas in humans, suggesting a tumor trophic function for the SVZ. Further studies showed that SVZ cells migrate out towards a peripheral glioblastoma. Dopamine signaling through D3 subtype receptor indirectly drives this centrifugal migration in humans. Since psychiatry has several drugs with good D3 blocking attributes, such as fluphenazine, or perphenazine, we suggest that adding one of these D3 blocking drugs to current standard treatment of resection followed by temozolomide and irradiation might prolong survival by depriving glioblastoma of the trophic functions previously subserved by dopaminergic signaling on SVZ cells.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kast</LastName>
            <ForeName>R E</ForeName>
            <Initials>RE</Initials>
            <AffiliationInfo>
              <Affiliation>IIAIGC Study Center, 22 Church Street, Burlington, VT, 05401, USA, richarderickast@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ellingson</LastName>
            <ForeName>B M</ForeName>
            <Initials>BM</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Marosi</LastName>
            <ForeName>C</ForeName>
            <Initials>C</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Halatsch</LastName>
            <ForeName>M-E</ForeName>
            <Initials>ME</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2013</Year>
          <Month>11</Month>
          <Day>17</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Neurooncol</MedlineTA>
        <NlmUniqueID>8309335</NlmUniqueID>
        <ISSNLinking>0167-594X</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D018492">Dopamine Antagonists</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>FTA7XXY4EZ</RegistryNumber>
          <NameOfSubstance UI="D010546">Perphenazine</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001932" MajorTopicYN="N">Brain Neoplasms</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002552" MajorTopicYN="N">Cerebral Ventricles</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018492" MajorTopicYN="N">Dopamine Antagonists</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005909" MajorTopicYN="N">Glioblastoma</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014411" MajorTopicYN="N">Neoplastic Stem Cells</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010546" MajorTopicYN="N">Perphenazine</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2013</Year>
          <Month>8</Month>
          <Day>8</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2013</Year>
          <Month>11</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2013</Year>
          <Month>11</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2013</Year>
          <Month>11</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2014</Year>
          <Month>9</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">24242756</ArticleId>
        <ArticleId IdType="doi">10.1007/s11060-013-1308-y</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>AJNR Am J Neuroradiol. 2013 Mar;34(3):533-40</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22997168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMC Cancer. 2010 Jul 21;10:384</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20663133</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Neurosci. 2008 Feb 27;28(9):2231-41</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18305256</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Front Genet. 2013 Oct 08;4:194</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24115953</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Exp Neurol. 2009 Oct;219(2):543-52</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19619535</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):609-15</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23462418</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Neurooncol. 2011 Aug;104(1):261-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21132516</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int J Cancer. 2011 Aug 1;129(3):574-85</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20886597</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>PLoS One. 2012;7(11):e49087</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23166605</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oncotarget. 2013 Apr;4(4):502-30</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23594434</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ann Surg Oncol. 2012 Jul;19 Suppl 3:S608-19</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21989663</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Clin Psychiatry. 2011 Jan;72(1):75-80</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20868641</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brain Tumor Pathol. 2014 Apr;31(2):77-84</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23670138</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Cancer. 2009 Nov;45(16):2893-905</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19679463</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cochrane Database Syst Rev. 2005 Jan 25;(1):CD003443</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15674907</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stem Cells. 2008 Nov;26(11):2945-54</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18757298</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neuro Oncol. 2007 Oct;9(4):424-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17622647</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Neurooncol. 2012 Aug;109(1):195-203</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22555992</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Biol Chem. 2012 Mar 16;287(12):8864-78</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22291025</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oncotarget. 2011 Aug;2(8):590-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21896959</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Pharmacol. 1993 Jan 15;244(2):199-201</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8094338</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Neurochem. 2004 Dec;91(6):1292-301</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15584906</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Semin Oncol. 2009 Aug;36(4 Suppl 2):S17-24</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19660679</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neuroscience. 2008 Sep 22;156(1):81-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18682279</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):616-22</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23540348</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neuroimage. 2012 Jan 16;59(2):908-16</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22001163</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Neurooncol. 2010 Feb;96(3):359-67</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19655089</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neuropharmacology. 2011 May;60(6):892-900</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21272591</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Curr Opin Pharmacol. 2010 Feb;10(1):100-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19896900</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Glia. 2013 Apr;61(4):475-89</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23322492</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Anaesthesiol. 2010 Dec;27(12):1044-51</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20739894</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Biochem Pharmacol. 2004 May 1;67(9):1689-700</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15081868</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Prog Brain Res. 2000;127:1-11</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11142024</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Neurosci. 2011 Mar;33(6):1123-32</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21395856</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neuron. 2013 Oct 16;80(2):442-57</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24139044</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Affect Disord. 1993 Jun;28(2):125-31</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8354768</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Proc Natl Acad Sci U S A. 2009 May 26;106(21):8754-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19433789</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neurobiol Dis. 2005 Apr;18(3):523-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15755679</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Turk Neurosurg. 2010 Oct;20(4):425-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20963689</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Pharmacol. 2011 Sep;666(1-3):43-52</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21658377</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Neurochem. 2010 Aug;114(3):750-60</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20477937</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Neurosci. 2005 Mar 9;25(10):2637-46</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15758174</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neoplasia. 2007 Aug;9(8):689</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17786188</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neuroreport. 2011 Dec 21;22(18):956-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22027511</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>PLoS One. 2012;7(4):e35150</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22539956</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
